Foresite Capital Management V

Latest statistics and disclosures from Foresite Capital Management V's latest quarterly 13F-HR filing:

Tip: Access up to 7 years of quarterly data

Positions held by Foresite Capital Management V consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Foresite Capital Management V

Companies in the Foresite Capital Management V portfolio as of the December 2020 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Kinnate Biopharma (KNTE) 25.8 $35M 875k 39.78
Alx Oncology Hldgs (ALXO) 20.4 $28M 320k 86.20
Relay Therapeutics (RLAY) 12.3 $17M 400k 41.56
Nurix Therapeutics (NRIX) 11.0 $15M 452k 32.88
Oaktree Acquisition Corp. Shs Cl A 9.4 $13M 871k 14.60
Population Health Investment Unit (PHICU) 7.4 $10M 960k 10.45
Therapeutics Acquisition Corp Com Cl A (RACA) 3.6 $4.9M 350k 13.92
Bctg Acquisition Corp (BCTG) 3.4 $4.6M 400k 11.44
Lifesci Acquisition Ii Corp (LSAQ) 3.2 $4.3M 400k 10.67
Helix Acquisition Corp. Com Cl A (HLXA) 2.1 $2.8M 250k 11.37
Consonance-HFW Acquisition Corp. Unit 0.8 $1.0M 100k 10.47
Abcellera Biologics (ABCL) 0.6 $805k 20k 40.25

Past Filings by Foresite Capital Management V

SEC 13F filings are viewable for Foresite Capital Management V going back to 2020